阿普米司特增加银屑病关节炎和银屑病患者IL-10阳性调节性B细胞并减少促炎T细胞和固有免疫细胞
该研究纳入20例银屑病关节炎和30例银屑病患者,观察阿普米司特治疗3、6、12个月后对调节性B细胞(Breg)及促炎细胞的影响。结果显示阿普米司特增加产生IL-10的B10细胞,且与皮肤和关节临床改善相关,同时减少IFNγ阳性T细胞、NKT细胞及IL-17阳性NKT细胞。提示Breg细胞是阿普米司特在PsA和银屑病中的主要靶点。
要点
- 阿普米司特治疗增加PsA和银屑病患者IL-10阳性B10细胞。
- B10细胞增加与银屑病皮肤和关节临床改善相关。
- 阿普米司特减少IFNγ阳性T细胞、NKT细胞和IL-17阳性NKT细胞。
核心结论
- Breg细胞是阿普米司特在PsA和银屑病中的主要靶点。
- 阿普米司特诱导的Breg细胞增加与Th1细胞、IFNγ阳性NKT细胞和IL-17阳性NKT细胞减少相关。
研究设计与样本
- 采用流式细胞术检测ODN2006(TLR9)刺激的外周血单个核细胞和磁珠分选细胞,并检测Th1细胞、Th17细胞和NKT细胞。
主要发现
- 体外刺激细胞分析显示,阿普米司特治疗后所有PsA和银屑病患者(IL-10+CD19+)B10细胞增加。
- B10细胞增加与银屑病皮肤和关节临床改善相关。
- 阿普米司特减少IFNγ阳性T细胞、NKT细胞和IL-17阳性NKT细胞。
- B10细胞与Th1细胞及IFNγ阳性NKT细胞呈负相关。
临床怎么用
- 阿普米司特可通过增加Breg细胞并抑制促炎T细胞和固有免疫细胞发挥免疫调节作用。
- B10细胞变化与临床改善相关,可作为监测阿普米司特疗效的潜在免疫学指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Psoriatic arthritis (PsA) and psoriasis are immune-mediated inflammatory diseases sharing common immunological mechanisms. Regulatory B cells (Breg cells) producing IL-10 (B10 cells), a critical anti-inflammatory B-cell subset, were found to be decreased in both PsA and psoriasis. Apremilast, a phosphodiesterase-4(PDE4) inhibitor, increases IL-10 and therefore, we examined the effect of apremilast on Breg cells. METHODS: Fifty patients, including 20 with PsA and 30 with psoriasis, were included in the study. The effect of apremilast on Breg cells at 3, 6 and 12 months post-treatment, was examined by flow cytometry in ODN2006 (TLR9)-stimulated peripheral blood mononuclear cells and magnetically-isolated cells. Th1 cells, Th17 cells and NKT were also measured. RESULTS: Ex vivo stimulated cell analysis identified that post-apremilast (IL-10+CD19+) B10 cells were increased in all PsA and psoriasis patients and correlated with psoriatic skin and joint clinical improvement. Apremilast decreased IFNγ(+) T and NKT cells and IL-17(+)NKT cells. B10 cells also inversely correlated with Th1 cells, and IFNγ(+)NKT cells. CONCLUSION: These results suggest that Breg cells are a major target of apremilast in PsA and psoriasis and that apremilast-induced increase of Breg cells is associated with a decrease of Th1 cells, IFNγ-producing NKT cells and IL-17-producing NKT cells.
引用
- Mavropoulos A, Zafiriou E, Simopoulou T, et al. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis. Rheumatology (Oxford). 2019. PMID: 31209492. doi:10.1093/rheumatology/kez204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。